Articles by P. M Ridker (9)

Metabolic Syndrome, Inflammation, and Risk of Symptomatic Peripheral Artery Disease in Women: A Prospective Study

D Conen, K. M Rexrode, M. A Creager and P. M Ridker

Circulation 120 ( 12 ): 1041 - 1047 , 2009

Rosuvastatin in the Prevention of Stroke Among Men and Women With Elevated Levels of C-Reactive Protein: Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER)

B. M Everett, R. J Glynn, J. G MacFadyen and P. M Ridker

Circulation 121 ( 1 ): 143 - 150 , 2010

Statins for the Primary Prevention of Cardiovascular Events in Women With Elevated High-Sensitivity C-Reactive Protein or Dyslipidemia: Results From the Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) and Meta-Analysis of Women From Primary Prevention Trials

S Mora, R. J Glynn, J Hsia, J. G MacFadyen, J Genest and P. M Ridker

Circulation 121 ( 9 ): 1069 - 1077 , 2010

Novel Loci, Including Those Related to Crohn Disease, Psoriasis, and Inflammation, Identified in a Genome-Wide Association Study of Fibrinogen in 17 686 Women: The Women's Genome Health Study

J. S Danik, G Pare, D. I Chasman, R. Y.L Zee, D. J Kwiatkowski, A Parker, J. P Miletich and P. M Ridker

Circulation: Cardiovascular Genetics 2 ( 2 ): 134 - 141 , 2009

Novel Associations of CPS1, MUT, NOX4, and DPEP1 With Plasma Homocysteine in a Healthy Population: A Genome-Wide Evaluation of 13 974 Participants in the Women's Genome Health Study

G Pare, D. I Chasman, A. N Parker, R. R.Y Zee, A Malarstig, U Seedorf, R Collins, H Watkins, A Hamsten, J. P Miletich and P. M Ridker

Circulation: Cardiovascular Genetics 2 ( 2 ): 142 - 150 , 2009

Number Needed to Treat With Rosuvastatin to Prevent First Cardiovascular Events and Death Among Men and Women With Low Low-Density Lipoprotein Cholesterol and Elevated High-Sensitivity C-Reactive Protein: Justification for the Use of statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)

P. M Ridker, F. A.H Fonseca, J Genest, A. M Gotto, J. J.P Kastelein, W Koenig, P Libby, A. J Lorenzatti, B. G Nordestgaard, J Shepherd, J. T Willerson, R. J Glynn and for the JUPITER Study Group

Circulation: Cardiovascular Quality and Outcomes 2 ( 6 ): 616 - 623 , 2009

Rosuvastatin for Primary Prevention Among Individuals With Elevated High-Sensitivity C-Reactive Protein and 5% to 10% and 10% to 20% 10-Year Risk: Implications of the Justification for Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) Trial for "Intermediate Risk"

P. M Ridker, J. G MacFadyen, B. G Nordestgaard, W Koenig, J. J. P Kastelein, J Genest and R. J. Glynn

Circulation: Cardiovascular Quality and Outcomes 3 ( 5 ): 447 - 452 , 2010

Variation in Recovery: Role of Gender on Outcomes of Young AMI Patients (VIRGO) Study Design

J. H Lichtman, N. P Lorenze, G D'Onofrio, J. A Spertus, S. T Lindau, T. M Morgan, J Herrin, H Bueno, J. A Mattera, P. M Ridker and H. M. Krumholz

Circulation: Cardiovascular Quality and Outcomes 3 ( 6 ): 684 - 693 , 2010

Socioeconomic status, blood pressure progression, and incident hypertension in a prospective cohort of female health professionals

D Conen, R. J Glynn, P. M Ridker, J. E Buring and M. A. Albert

European Heart Journal 30 ( 11 ): 1378 - 1384 , 2009